Case number 1:19-cv-01734
Genzyme Corp. et al v. Aizant Drug Research Solutions Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 11, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [148] in Lead C.A. No. 18-1795-CFC. (fms) |
| Oct 10, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01795-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1795-CFC. (nmf) |
| Oct 10, 2019 | 9 | SO ORDERED (2) Docket Text: SO ORDERED, re (57 in 1:18-cv-01795-CFC, 8 in 1:19-cv-01734-CFC) STIPULATION AND ORDER OF CONSOLIDATION. The parties shall be bound by the Scheduling Order entered on February 4, 2019 in Civ. No. 18-1795-CFC, D.I. 18. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1795-CFC ONLY. Signed by Judge Colm F. Connolly on 10/10/2019. Associated Cases: 1:18-cv-01795-CFC, 1:19-cv-01734-CFC(nmf) |
| Oct 9, 2019 | 8 | Stipulation (2) Docket Text: STIPULATION of Consolidation by Genzyme Corp., The Regents of the University of Michigan. (Fahnestock, Derek) |
| Oct 1, 2019 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aizant Drug Research Solutions Private Limited. (Farnan, Kelly) |
| Sep 30, 2019 | 6 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Aizant Drug Research Solutions Private Limited.(Mosley, Renee) |
| Sep 18, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Sep 16, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aizant Drug Research Solutions Private Limited on 9/16/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Sep 16, 2019 | 1 | Exhibit A-C (89) |
| Sep 16, 2019 | 1 | Civil Cover Sheet (1) |
| Sep 16, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Sep 16, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/13/2019. Date of Expiration of Patent: 4/29/2022.Thirty Month Stay Deadline: 2/19/2022. (lak) |
| Sep 16, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,916,802 B2 ;7,253,185 B2 ;7,615,573 B2. (lak) |
| Sep 16, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aventis Inc., Corporate Parent Sanofi for Genzyme Corp. filed by Genzyme Corp. Plaintiff The Regents of the University of Michigan has no parent corporation and nobody owns stock in it. (lak) |
| Sep 16, 2019 | 1 | Complaint* (1) |
